Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Codexis, a provider of optimised biocatalysts, has appointed Peter Strumph as senior vice president of commercial operations. Mr Strumph will be responsible for product management and manufacturing operations worldwide.
Subscribe to our email newsletter
Codexis has commercialised its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration.
Codexis said that Mr Strumph will report to Joseph Sarret, chief business officer and president of pharmaceutical services and enzyme products.
Mr Strumph joins Codexis with 20 years experience in senior manufacturing and operations management in the biopharmaceutical industry. He was CEO of Nile Therapeutics from 2007-2009.
Dr Sarret said: “Peter Strumph brings Codexis extensive manufacturing management experience, with a focus on commercialising pharmaceuticals products.
“His breadth of experience in managing successful global pharmaceuticals operations will enable us to better serve our expanding customer base.”